13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


臨床試験数 : 3,340 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01448252
(ClinicalTrials.gov)
May 20025/10/2011T Cell Vaccination in Patients With Progressive Multiple SclerosisAutologous T Cell Vaccination With Line Specific for 9 Myelin Peptides in Patients With Progressive / Relapsing Multiple SclerosisMultiple SclerosisBiological: multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides);Biological: T cell vaccinationHadassah Medical OrganizationNULLCompleted18 Years60 YearsBoth30Phase 1/Phase 2Israel
2NCT00228228
(ClinicalTrials.gov)
May 200226/9/2005TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple SclerosisT-Cell Vaccination in the Treatment of Probable Multiple SclerosisMultiple SclerosisBiological: T cell vaccinationSheba Medical CenterNULLRecruiting15 Years50 YearsBoth80Phase 3Israel